A derivative of the CRMP2 binding compound lanthionine ketimine provides neuroprotection in a mouse model of cerebral ischemia |
| |
Authors: | Shadia E. Nada Jatin Tulsulkar Aparna Raghavan Kenneth Hensley Zahoor A. Shah |
| |
Affiliation: | 1. Department of Medicinal and Biological Chemistry, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, OH, USA;2. Department of Pathology, Health Sciences Campus, University of Toledo, OH 43614, USA;3. Department of Neuroscience, Health Sciences Campus, University of Toledo, OH 43614, USA |
| |
Abstract: | Lanthionines are novel neurotrophic and neuroprotective small molecules that show promise for the treatment of neurodegenerative diseases. In particular, a recently developed, cell permeable lanthionine derivative known as LKE (lanthionine ketimine 5-ethyl ester) promotes neurite growth at low nanomolar concentrations. LKE also has neuroprotective, anti-apoptotic, and anti-inflammatory properties. Its therapeutic potential in cerebral ischemia and its mechanisms of neurotrophic action remain to be fully elucidated. Here, we hypothesize that the neuroprotective actions of LKE could result from induction or modulation of CRMP2. We found that treating primary cultured mouse neurons with LKE provided significant protection against t-butyl hydroperoxide-induced neuronal death possibly through CRMP2 upregulation. Similarly, in vivo studies showed that LKE pre and/or post-treatment protects mice against permanent distal middle cerebral artery occlusion (p-MCAO) as evidenced by lower stroke lesions and improved functional outcomes in terms of rotarod, grip strength and neurologic deficit scores in treated groups. Protein expression levels of CRMP2 were higher in brain cortices of LKE pretreated mice, suggesting that LKE’s neuroprotective activity may be CRMP2 dependent. Lower activity of cleaved PARP-1 and higher activity of SIRT-1 was also observed in LKE treated group suggesting its anti-apoptotic properties. Our results suggest that LKE has potential as a therapeutic intervention in cerebral ischemia and that part of its protective mechanism may be attributed to CRMP2 mediated action and PARP-1/SIRT-1 modulation. |
| |
Keywords: | CRMP2, collapsin response mediator protein 2 H2O2, hydrogen peroxide LKE, lanthionine ketimine-ethyl ester MCAO, middle cerebral artery occlusion NDS, neurologic deficit score t-BuOOH, tertiary butylhydroperoxide TFM, terpene free material p-MCAO, permanent distal middle cerebral artery occlusion PARP-1, poly(ADP-ribose) polymerase-1 TTC, triphenyltetrazolium chloride SIRT-1, situin-1 |
本文献已被 ScienceDirect 等数据库收录! |
|